A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Chromosome Analysis, Blood
Test Code14596
CPT Codes
88230, 88262
Physician Attestation of Informed Consent
This germline genetic test requires physician attestation that patient consent has been received if ordering medical facility is located in AK, DE, FL, GA, IA, MA, MN, NV, NJ, NY, OR, SD or VT or test is performed in MA.
Includes
**Test may be replaced by %37871 Chromosome Analysis, Blood, No Growth and %39650 Cytogenetics Communication**
Preferred Specimen
5 mL whole blood collected in a sodium heparin (green-top) tube
Minimum Volume
1 mL
Critical NICU/Neonates 0.5 mL
Critical NICU/Neonates 0.5 mL
Other Acceptable Specimens
Sodium heparin (royal blue-top) tube • Sodium heparin lead-free (tan-top) tube
Instructions
Other vacutainer tubes containing sodium heparin are acceptable. See Genetics Specimen Collection Section for detailed specimen instructions.
Transport Temperature
Room temperature
Specimen Stability
Room temperature: Preferred
Refrigerated: Acceptable
Frozen: Unacceptable
Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not freeze. Do not reject.
Refrigerated: Acceptable
Frozen: Unacceptable
Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not freeze. Do not reject.
Methodology
Culture • Karyotype • Microscopy
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
A.M. Sets up 7 days a week.
Clinical Significance
This test may assist with the detection of common chromosome abnormalities.